Syphilis: today

被引:3
作者
Ponyai, Katinka [1 ]
Ostorhazi, Eszter [1 ]
Marschalko, Marta [1 ]
Karpati, Sarolta [1 ]
Rozgonyi, Ferenc [1 ]
机构
[1] Semmelweis Univ, Dept Dermatol Venereol & Dermatooncol, Microbiol Lab, Natl STD Diagnost Ctr, H-1085 Budapest, Hungary
关键词
clinical manifestations; diagnosis; management; sexually transmitted infections; syphilis; therapy; Treponema pallidum; VIRULENT TREPONEMA-PALLIDUM; MICROVASCULAR ENDOTHELIAL-CELLS; AZITHROMYCIN RESISTANCE; SECONDARY SYPHILIS; SUBSP PALLIDUM; NICHOLS STRAIN; INFECTION; PROTEINS; ATTACHMENT; DIAGNOSIS;
D O I
10.1097/MRM.0b013e32833e6a0f
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Thanks to the introduction of antibiotic therapy, syphilis has become a curable disease. In December 1954, the famous Hungarian venereologist Erno Kalman, MD, trustingly wrote in his paper published in the Nepegeszsegugy (National Health): 'Based on the results up to now, one may reasonably expect that the practical elimination of new infections with syphilis will become a reality within 1 to 2 years'. This optimistic vision of the future has not come true, as the incidence of syphilis has shown an increasing trend again worldwide, in spite of successful antibiotic therapy being readily available. From the end of the 1990s, Hungarian data reflect the epidemiological trend observed worldwide; a slow decrease was evident until 2004 and stagnation since 2005. With the exception of 2007, more than 500 fresh infections were diagnosed in the country in each year, with an increase of cases diagnosed during pregnancy, as well as among the newborn with congenital syphilis. The current article reviews the detailed microbiology of Treponema pallidum, the clinical manifestations and diagnostic clues relating to different stages of the disease, the diagnostic algorithms, management, therapy, follow-up, and prevention not only of acquired but also of congenital syphilis as well. (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:84 / 95
页数:12
相关论文
共 51 条
  • [21] HANFF PA, 1983, J IMMUNOL, V131, P1973
  • [22] JEPSEN OB, 1968, ACTA PATHOL MIC SC, V74, P241
  • [23] Azithromycin resistance in Treponema pallidum
    Katz, Kenneth A.
    Klausner, Jeffrey D.
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2008, 21 (01) : 83 - 91
  • [24] Biological basis for syphilis
    LaFond, RE
    Lukehart, SA
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2006, 19 (01) : 29 - +
  • [25] LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1
  • [26] Antibody responses elicited against the Treponema pallidum repeat proteins differ during infection with different isolates of Treponema pallidum subsp pallidum
    Leader, BT
    Hevner, K
    Molini, BJ
    Barrett, LK
    Van Voorhis, WC
    Lukehart, SA
    [J]. INFECTION AND IMMUNITY, 2003, 71 (10) : 6054 - 6057
  • [27] Leão Jair Carneiro, 2006, Clinics, V61, P161
  • [28] Receptors for Treponema pallidum attachment to the surface and matrix proteins of cultured human dermal microvascular endothelial cells
    Lee, JH
    Choi, HJ
    Jung, J
    Lee, MG
    Lee, JB
    Lee, KH
    [J]. YONSEI MEDICAL JOURNAL, 2003, 44 (03) : 371 - 378
  • [29] Virulent Treponema pallidum 47 kDa antigen regulates the expression of cell adhesion molecules and binding of T-lymphocytes to cultured human dermal microvascular endothelial cells
    Lee, KH
    Choi, HJ
    Lee, MG
    Lee, JB
    [J]. YONSEI MEDICAL JOURNAL, 2000, 41 (05) : 623 - 633
  • [30] A SUBPOPULATION OF TREPONEMA-PALLIDUM IS RESISTANT TO PHAGOCYTOSIS - POSSIBLE MECHANISM OF PERSISTENCE
    LUKEHART, SA
    SHAFFER, JM
    BAKERZANDER, SA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (06) : 1449 - 1453